C the Signs is a healthcare AI company built around a deceptively simple but high-impact idea: most cancers are far more survivable when caught early, yet the signals of early-stage disease are often buried in routine clinical data and missed. The company has developed an artificial-intelligence platform that identifies patients at risk of cancer at the earliest and most curable stage, helping clinicians act before the disease progresses.
The platform works by analyzing data already present in patient electronic health records, going well beyond basic indicators like age and gender to examine a wide array of personal and environmental data points. Crucially, the model is explainable, meaning it surfaces the reasoning behind each risk assessment so that clinicians can understand and trust its recommendations. This explainability is essential for clinical adoption, where opaque predictions are difficult to act on and harder to integrate into care pathways.
C the Signs has accumulated substantial real-world evidence within the United Kingdom's National Health Service, where it has helped detect tens of thousands of cancers. The company reports striking results, including identifying a meaningful share of breast cancer cases up to five years earlier than standard pathways and outperforming traditional methods in early-stage ovarian cancer detection. This track record within a national health system provides rare validation for an AI diagnostic-support tool.
In January 2025 the company announced an $8 million investment from Khosla Ventures to advance its AI-powered early cancer detection and accelerate its expansion from the UK into the United States. C the Signs is backed by investors including Khosla Ventures, MMC, Ataraxia, and Acequia Capital, alongside notable angels such as former leaders of major health insurers and the founder of Monzo. By turning existing health-record data into earlier, explainable cancer-risk signals, C the Signs aims to shift cancer detection upstream where outcomes are dramatically better.